Real-world clinical outcome of cefiderocol for treatment of multidrug-resistant non-fermenting, gram negative bacilli infections: a case series

被引：18

作者：

Hoellinger, Baptiste ^{[1
,9
]}

Simand, Celestine ^{[2
]}

Jeannot, Katy ^{[3
]}

Garijo, Carlos ^{[4
]}

Cristinar, Mircea ^{[5
]}

Reisz, Fanny ^{[6
]}

Danion, Francois ^{[1
]}

Ursenbach, Axel ^{[1
]}

Lefebvre, Nicolas ^{[1
]}

Boyer, Pierre ^{[7
]}

Hansmann, Yves ^{[1
]}

Studer, Antoine ^{[8
]}

Schramm, Frederic

Ruch, Yvon ^{[1
]}

机构：

[1] Hop Univ Strasbourg, Dept Infect & Trop Dis, Strasbourg, France

[2] Strasbourg Univ, Inst Canc Strasbourg Europe, Dept Hematol, Strasbourg, France

[3] Ctr Hosp Univ Besancon, Ctr Natl Reference Resistance Antibiot, Lab Associe, Besancon, France

[4] Hop Univ Strasbourg, Serv Reanimat Med Hautepierre, Strasbourg, France

[5] Hop Univ Strasbourg, Nouvel Hop Civil, Serv Reanimat Chirurgicale, Strasbourg, France

[6] Hop Univ Strasbourg, Dept Pharm, Strasbourg, France

[7] Hop Univ Strasbourg, Dept Bacteriol, Strasbourg, France

[8] Hop Univ Strasbourg, Nouvel Hop Civil, Serv Med Intens Reanimat, Strasbourg, France

[9] Hop Univ Strasbourg, Dept Infect Dis, F-67000 Strasbourg, France

来源：

CLINICAL MICROBIOLOGY AND INFECTION | 2023年 / 29卷 / 03期

关键词：

D O I：

10.1016/j.cmi.2022.11.005

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：393 / 395

页数：3

共 50 条

[21] NON-FERMENTING GRAM-NEGATIVE BACILLI ASSOCIATED WITH ACUTE RESPIRATORY-INFECTIONS IN CHILDREN IN MADRAS
PARAMASIVAN, CN
SIVADASAN, K
DATTA, M
VALLISHAYEE, RS
PRABHAKAR, R
JOURNAL OF TROPICAL PEDIATRICS, 1987, 33 (06) : 343 - 345
[22] Pharmacokinetic evaluation of cefiderocol for the treatment of multidrug resistant Gram-negative infections
Drwiega, Emily N.
Griffith, Nicole C.
Danziger, Larry H.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2022, 18 (04) : 245 - 259
[23] Treatment of Multidrug-Resistant Gram-Negative Infections in Children
Hsu, Alice J.
Tamma, Pranita D.
CLINICAL INFECTIOUS DISEASES, 2014, 58 (10) : 1439 - 1448
[24] In Vitro Activity of Cefiderocol Against Multidrug-Resistant Gram-Negative Clinical Isolates
Boyd, Sandra
Anderson, Karen
Karlsson, J. Kamile Rasheed Maria
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2020, 41 : S291 - S292
[25] Clinical Characteristics and Risk Factors for Fatality in Patients with Bloodstream Infections Caused by Glucose Non-fermenting Gram-negative Bacilli
Chang, Tzu-Yao
Lee, Chen-Hsiang
Liu, Jien-Wei
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2010, 43 (03) : 233 - 239
[26] Clinical and economic impact of common multidrug-resistant gram-negative bacilli
Giske, Christian G.
Monnet, Dominique L.
Cars, Otto
Carmeli, Yehuda
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (03) : 813 - 821
[27] Repurposing of the Tamoxifen Metabolites to Combat Infections by Multidrug-Resistant Gram-Negative Bacilli
Miro-Canturri, Andrea
Ayerbe-Algaba, Rafael
Vila-Dominguez, Andrea
Jimenez-Mejias, Manuel E.
Pachon, Jeronimo
Smani, Younes
ANTIBIOTICS-BASEL, 2021, 10 (03):
[28] Potential Tamoxifen Repurposing to Combat Infections by Multidrug-Resistant Gram-Negative Bacilli
Miro-Canturri, Andrea
Ayerbe-Algaba, Rafael
del Toro, Raquel
Mejias, Manuel Enrique-Jimenez
Pachon, Jeronimo
Smani, Younes
PHARMACEUTICALS, 2021, 14 (06)
[29] Multidrug-Resistant Gram-Negative Infections What are the Treatment Options?
Giamarellou, Helen
Poulakou, Garyphallia
DRUGS, 2009, 69 (14) : 1879 - 1901
[30] The clinical impact of multidrug-resistant gram-negative bacilli in the management of septic shock
Pop-Vicas, Aurora
Opal, Steven M.
VIRULENCE, 2014, 5 (01) : 206 - 212

← 1 2 3 4 5 →